Functional Tumours: (1) Identify origin of functional duodenal/pancreatic NETs and/or (2) identify origin of elevated biochemical markers (e.g. CgA) and/or (3) ZES—monitoring of NETs difficult to seen on MRI/detection NETs not seen on MRI. This evidence concerns the gene CGA and neoplasm.